Physicians:
ACCME
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and Sentinel Node Oncology Foundation. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
USF Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is has been approved for 14.50 contact hours.
Target Audience
This activity is intended for physicians specializing in surgery, oncology, molecular imaging, plastic surgery, radiation oncology, hematology, thoracic medicine with the remainder a mixture of predominately PhD/scientists from both academia and biotechnology as well as a smaller groups of attendees who are in training
Learning Objectives
Upon completion of this activity, participants will be able to:
Describe cancer initiation, progression and dormancy in the cancer microenvironment
Describe the complexity of cancer microenvironment
Describe the development of resistant cancer clones from immunotherapy and targeted therapy
Recognize the utility of SLN biopsy in multiple cancers and that SLN may be the primary gateway to cancer metastasis
Explain the clinical utility of liquid biopsy to detect circulating cancer cells or ctDNA
Describe the molecular mechanisms of breast cancer metastasis
Distinguish the pathways of metastasis by virtue of the lymphatic versus blood vessels
Describe the novel frontiers in the treatment of metastatic melanoma based on its mechanisms of metastasis
Describe oncolymphology: immune system and cancer
Discuss the application of immune check point inhibition and targeted therapy against cancer for personalized cancer treatment
Describe the potential application of molecular imaging for pinpoint stereotactic radiotherapy
Identify secondary lymphedema resulting from cancer treatment and methods to overcome lymphedema
Disclosure
USF Health adheres to ACCME Standards regarding commercial support of continuing medical education. It is the policy of USF Health that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the course syllabus.
Disclaimer
The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
Share this: